Abbott Laboratories Profit Margin

The latest profit margin for ABL.DE is 11.65% as of June 2026. That compares with 32.43% in the prior-year period — down 64.1% year over year. That is below the Healthcare sector average of 13.39%. Investors often review this figure alongside Abbott Laboratories's historical trend and sector peers before judging valuation or financial health.

Over the past year, ABL.DE's profit margin moved from 32.43% to 11.65% — a 64.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Abbott Laboratories's valuation or profitability profile.

Against Healthcare companies, ABL.DE currently prints 11.65% for profit margin, while the sector average sits near 13.39%. That is roughly 13.0% below the sector mean. Large gaps often invite a closer look at Abbott Laboratories's growth, margins, and balance sheet.

Profit Margin shows how effectively Abbott Laboratories converts resources into returns. At 11.65%, ABL.DE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 32.43% in the prior-year period — down 64.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ABL.DE's profit margin (11.65%), review year-over-year change from 32.43%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.